Earnings
Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation
Revenue Growth Validates Model But Unsustainable Burn Rate Signals Near-Term Dilution Risk

Executive Summary
- Rocket Doctor AI Inc. reported FY2025 audited financial results for the year ended December 31, 2025.
- Annual revenue reached $1.739 million, a massive increase from $10,990 in 2024, driven by U.S. payer contracts.
- Q4 2025 revenue was $697,340, representing sequential growth of 31.8% and year-over-year growth of 36.1%.
- Net loss for Q4 2025 was $7.3 million ($0.10 per share), with adjusted EBITDA loss of $2.1 million.
- Cash and cash equivalents as of December 31, 2025, were $641,779 prior to recent financing activities.
- The company completed a $5.2 million private placement in January 2026 and generated ~$2.05 million from warrant exercises during the quarter.
- U.S. network reach expanded to over 21 million members through contracts in California, New York, and Maryland.
- Acquisition of Alea Health Holdings Ltd. was completed on January 8, 2026, adding mental health capabilities.
Material Impact
- The earnings release confirms the company's transition from concept to scalable operations but highlights a critical financial sustainability issue.
- Revenue growth is significant (150x year-over-year), validating the U.S. expansion strategy and payer contracts announced in late 2025.
- However, the Q4 net loss of $7.3 million against annual revenue of only $1.7 million indicates a burn rate that exceeds current cash reserves by more than four times annually.
- While the January 2026 financing ($5.2M) and warrant exercises (~$2M) provided immediate liquidity, the Q4 loss suggests these funds may be depleted within one quarter if spending continues at this pace.
- The news is Routine - Negative because it confirms expected high burn for a growth-stage company but signals an urgent need for additional capital raising in the near future (likely Q2/Q3 2026).
- No strategic investors like Sprott or Lundin were disclosed, and no M&A beyond Alea Health was announced that would alter valuation significantly.
AIDR · Price
Company Overview
- Company: Rocket Doctor AI Inc., a digital health platform provider focusing on physician-led virtual care powered by AI.
- Flagship Project: The Rocket Doctor marketplace connecting patients with board-certified physicians via an AI-enabled platform (Global Library of Medicine).
- Development Status: Transitioned from proof-of-concept to U.S. commercial scaling in 2025/2026.
- Key Assets: In-network contracts covering >21 million members, proprietary AI clinical decision support tools, and the recently acquired Alea Health mental health platform.
- Geographic Focus: Primarily Canada (Alberta) and expanding rapidly into U.S. markets (California, New York, Maryland).
More from Rocket Doctor AI Inc.
Jun 30, 2026 · 08:00